(chloroprocaine Hci Injection, Solution
Product Images NDC 51662-1407

13 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for (chloroprocaine Hci (NDC 51662-1407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Chloroprocaine HCl, showing the benzene ring with amino and chlorine substituents, and the ester side chain linked to a diethylamino group along with the hydrochloride component.*
FDA Label Image

Description (Description 1)

Description (Description 1)
A table displaying the formula composition in mg/mL for several Nesacaine products. It lists Chloroprocaine HCl, Sodium Chloride, Disodium EDTA dihydrate, and Methylparaben concentrations across four formulations: Nesacaine 1%, Nesacaine 2%, Nesacaine-MPF 2%, and Nesacaine-MPF 3%.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A data table categorizing various drug classes with examples, including nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. The table lists specific examples such as lidocaine under local anesthetics and chloroquine under antimalarials.*
FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
A dosage table for chloroprocaine HCl injection, solution, showing anesthetic procedures, solution concentration percentages, volume in mL, and total dose in mg. Procedures include mandibular, infraorbital, brachial plexus, digital (without epinephrine), pudendal, and paracervical with corresponding ranges for volume and dose.*
FDA Label Image
FDA Label Image

Vial 1 (Vial 1)

Vial 1 (Vial 1)
Nesacaine (chloroprocaine HCl Injection, USP) 1% (300 mg/30 mL, 10 mg/mL) multiple dose vial with a purple cap. Label indicates use for infiltration and nerve block only, not for caudal, epidural, or spinal anesthesia. Contains methylparaben. NDC 63323-475-37.*
FDA Label Image

Vial 2 (Vial 2)

Vial 2 (Vial 2)
A vial with a maroon flip-top cap containing a clear liquid. The label includes storage and handling instructions such as "Sterile, nonpyrogenic," "Do not autoclave," "Discard if solution is discolored," and "Protect from light." It also states to store between 20° to 25°C (68° to 77°F) and keep from freezing. The label displays Fresenius Kabi USA, LLC as the manufacturer in Lake Zurich, IL.*
FDA Label Image

Vial 3 (Vial 3)

Vial 3 (Vial 3)
A clear glass vial with a purple plastic cap and silver aluminum seal containing a clear liquid solution. The vial has a white label showing a barcode, lot number 6119548, and expiration date 07/20. The product is Chloroprocaine HCl injection, solution, 10 mg/mL, manufactured by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
Nesacaine 1% (chloroprocaine HCl Injection, USP) 300 mg/30 mL (10 mg/mL) clear solution in a 30 mL multiple dose vial with a magenta flip-off cap. Label indicates use for infiltration and nerve block only, distributed by HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Pouch Labeling (51662 1407 2 Pouch)

Pouch Labeling (51662 1407 2 Pouch)
Drug information panel for Nesacaine (Chloroprocaine HCl) Injection, USP 1% (10 mg/mL), 30 mL vial. Includes NDC 51662-1407-2, lot number, expiration date, barcode, administration warnings stating it is for infiltration and nerve block only, not for caudal or epidural use, and storage instructions. Also lists inactive ingredients and manufacturer as HF Acquisition Co LLC.*
FDA Label Image

Vial Label (Vial Label In Pouch)

Vial Label (Vial Label In Pouch)
Nesacaine (chloroprocaine HCl) Injection, USP 1% (10 mg/mL) solution for injection. Packaged in a 30 mL multiple dose vial. Label indicates use for infiltration and nerve block only, not for caudal, epidural, or spinal anesthesia. Contains methylparaben. Manufacturer: Fresenius Kabi, Lake Zurich, IL. Storage instructions include protecting from light, storing between 20° to 25°C, and keeping from freezing.*
FDA Label Image

Case Labeling (51662 1407 3 Case Labeling Updated)

Case Labeling (51662 1407 3 Case Labeling Updated)
Label for Nesacaine (Chloroprocaine HCl Injection) USP 1% (10 mg/mL) in a 30 mL vial, with 25 vials per case. The label includes NDC 51662-1407-3, lot number 123456, and expiration date 2039-01-01. It notes usage for infiltration and nerve block only, with storage instructions and manufacturer details for HF Acquisition Co, LLC.*
FDA Label Image

Rfid Label (51662 1407 3 Rfid)

Rfid Label (51662 1407 3 Rfid)
A white label with a black tear strip at the top and a white rectangular sticker containing black printed text and a QR code. The text includes identifiers such as (01)00351662140734, (17)230919, and distributor information for HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label is affixed to a clear plastic or glass surface, likely part of the product packaging for Chloroprocaine HCl injection solution by HF Acquisition Co LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.